Rep. Kuster Statement on FDA Emergency Use Authorization of 3rd COVID-19 Vaccine
February 28, 2021
February 28, 2021
WASHINGTON, Feb. 28 -- Rep. Ann Kuster, D-New Hampshire, issued the following statement:
* * *
Rep. Annie Kuster (NH-02), a member of the House Energy and Commerce Health Subcommittee, released the following statement after the Food and Drug Administration (FDA) issued an emergency use authorization of the Johnson & Johnson COVID-19 vaccine and hospitalizations for COVID-19 patients in New Hampshire fell below 100.
"The Johnson & Johnson vaccin . . .
* * *
Rep. Annie Kuster (NH-02), a member of the House Energy and Commerce Health Subcommittee, released the following statement after the Food and Drug Administration (FDA) issued an emergency use authorization of the Johnson & Johnson COVID-19 vaccine and hospitalizations for COVID-19 patients in New Hampshire fell below 100.
"The Johnson & Johnson vaccin . . .